CLGN
OtherCollPlant Biotechnologies Ltd New
Live · NASDAQ · May 9, Close
What's Moving CLGN Today?
No stock-specific AI insight has been generated for CLGN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
CLGN News
20 articles- CollPlant Issues Letter to ShareholdersYahoo Finance·Apr 13, 2026
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEYahoo Finance·Mar 26, 2026
- CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid RequirementYahoo Finance·Mar 24, 2026
- CollPlant Biotechnologies Launches Redesigned Corporate WebsiteYahoo Finance·Mar 18, 2026
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTSYahoo Finance·Mar 11, 2026
- CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal FillerYahoo Finance·Feb 26, 2026
- CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlexYahoo Finance·Feb 23, 2026
- CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss TreatmentsYahoo Finance·Feb 17, 2026
- When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit?Yahoo Finance·Feb 8, 2026
- CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offeringYahoo Finance·Feb 6, 2026
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERINGYahoo Finance·Feb 5, 2026
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEYahoo Finance·Nov 26, 2025
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTSYahoo Finance·Nov 18, 2025
- Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn SituationYahoo Finance·Nov 13, 2025
- CollPlant Expands its rhCollagen Distribution Capabilities in the United States and CanadaYahoo Finance·Oct 27, 2025
- CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of TechnologyYahoo Finance·Oct 20, 2025
- First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInkYahoo Finance·Oct 16, 2025
- One CollPlant Biotechnologies Insider Raised Their Stake In The Previous YearYahoo Finance·Oct 3, 2025
- CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue FillerYahoo Finance·Sep 30, 2025
- CollPlant Expands the Distribution of its VergenixSTR Product in EuropeYahoo Finance·Sep 15, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About CollPlant Biotechnologies Ltd New
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.